Phase II trial with S-1 in chemotherapy-nave patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG)

Author： Chollet P.   Schoffski P.   Weigang-Kohler K.   Schellens J.H.M.   Cure H.   Pavlidis N.   Grunwald V.   De Boer R.   Wanders J.   Fumoleau P.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.39, Iss.9, 2003-06, pp. : 1264-1270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

By Coudert B.   Anthoney A.   Fiedler W.   Droz J.P.   Dieras V.   Borner M.   Smyth J.F.   Morant R.   de Vries M.J.   Roelvink M.   Fumoleau P.  

European Journal of Cancer, Vol. 37, Iss. 17, 2001-01 ,pp. : 2194-2198

Elsevier

Access to resources Recommend Favorite

Results of a phase II trial with second-line cystemustine at 60mg/m 2 in advanced soft tissue sarcoma: A trial of the EORTC early clinical studies group

By Cure H.   Krakowski I.   Adenis A.   Tubiana N.   Kerbrat P.   Roche H.   Chevallier   Lentz M.A.   Fumoleau P.   Chollet P.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 422-423

Elsevier

Access to resources Recommend Favorite

Fotemustine in Patients with Advanced Gastric Cancer, a Phase II Trial From the EORTC-GITCCG (European Organization for Research and Treatment of Cancer, Gastrointestinal Tract Cancer Cooperative Group)

By the EORTC-GITCCG   Rougier P.   Van Pottelsberghe C.   Kok T.   Paillot B.   Wagener T.   De Greve J.   Fabri M.C.   Gerard B.   Van Glabbeke M.   Bleiberg H.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1432-1433

Elsevier

Access to resources Recommend Favorite

A Phase I/II Trial of Radiotherapy Concurrent with TS-1 Plus Cisplatin in Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1205

By Imano Motohiro   Furukawa Hiroshi   Yokokawa Masaki   Nishimura Yasumasa   Kurokawa Yukinori   Satoh Taroh   Sakai Daisuke   Yasuda Takushi   Imamoto Haruhiko   Tujinaka Toshimasa   Shimokawa Toshio   Shiozaki Hitoshi  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 4, 2013-04 ,pp. : 431-435

Oxford University Press

Access to resources Recommend Favorite

Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group

By van Wijk F.H.   Lhomme C.   Bolis G.   Scotto di Palumbo V.   Tumolo S.   Nooij M.   de Oliveira C.F.   Vermorken J.B.  

European Journal of Cancer, Vol. 39, Iss. 1, 2003-01 ,pp. : 78-85

Elsevier

Access to resources Recommend Favorite